HCPCS J-code
J0517: benralizumab
Benralizumab 1 mg (severe eosinophilic asthma)
Code
J0517
Generic
benralizumab
Brands
Fasenra
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- Eosinophil count threshold (≥300 cells/μL)
- Step therapy
Frequently asked questions
What is HCPCS J0517?
Benralizumab 1 mg (severe eosinophilic asthma)
Why does insurance commonly deny J0517?
Eosinophil count threshold (≥300 cells/μL); Step therapy.
What brand-name drug uses J0517?
Fasenra.
Related
Appeal a J0517 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com